Tyra Biosciences, Inc.
TYRA
$36.22
$0.220.61%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 11.44% | 4.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.84% | 4.74% | |||
| Operating Income | -10.84% | -4.74% | |||
| Income Before Tax | -13.28% | -6.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -13.28% | -6.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.28% | -6.30% | |||
| EBIT | -10.84% | -4.74% | |||
| EBITDA | -10.88% | -4.79% | |||
| EPS Basic | -12.99% | -6.08% | |||
| Normalized Basic EPS | -12.98% | -6.07% | |||
| EPS Diluted | -12.99% | -6.08% | |||
| Normalized Diluted EPS | -12.98% | -6.07% | |||
| Average Basic Shares Outstanding | 0.27% | 0.20% | |||
| Average Diluted Shares Outstanding | 0.27% | 0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||